Karyopharm Therapeutics is a biopharmaceutical company focusing on the development of novel drugs for the treatment of cancer, inflammation and diseases related to cell proliferation. Karyopharm Therapeutics is developing small molecule drugs that will modulate the activity of critical pathways in cancer, inflammation, and cell proliferation (e.g. FOXO, NFкB, P53, pRB) by targeting the nuclear pore complex machinery, which controls the import and export of proteins between the nucleus and cytoplasm. To successfully control transport through the nuclear pore complex, the company will use its unique technology platform, developed by Sharon Shacham, to identify novel small molecules, optimize them into clinical candidates, and to evaluate them in subsequent human clinical studies.Founded in 2008, Karyopharm is an established company that loves to hire graduates from Northeastern University, with 23.1% of its employees having attended Northeastern University. Karyopharm has established itself as a great place to work in Massachusetts, and it is number 16 on Zippia's list of Best Companies to Work for in Newton, MA.The average employee at Karyopharm makes $107,666 per year, which is quite competitive for its location and industry. In comparison, some of its highest paying competitors, like Vertex Pharmaceuticals, Akebia Therapeutics, and Hoffmann-LA Roche Inc, pay $95,952, $94,635, and $93,461, respectively.Karyopharm is a medium pharmaceutical company with 442 employees and an annual revenue of $145.2M that is headquartered in Massachusetts.
Karyopharm's mission statement
We seek to foster scientific creativity with pioneering technologies and developmental approaches within an innovative culture that will accelerate first-in-class small molecule modulators of nuclear transport into effective therapeutics for life-threatening conditions.
In demand companies are hiring! Let Zippia apply for you!
-
Karyopharm employee reviews
Be the first to review!
Do you work at Karyopharm?
Help job seekers learn about working at Karyopharm
The founders of Karyopharm are Sharon Shacham Ph.d, Michael G. Kauffman and Ronald Depinho.
The key people at Karyopharm are Sharon Shacham Ph.d, Michael G. Kauffman and Ronald Depinho.
Key people
Sharon Shacham Ph.d
Michael G. Kauffman
Ronald Depinho
Karyopharm rankings
Karyopharm is ranked #33 on the Best Pharmaceutical companies to work for in Massachusetts list. Zippia's Best Places to Work lists provide unbiased, data-based evaluations of companies. Rankings are based on government and proprietary data on salaries, company financial health, and employee diversity.
Rate Karyopharm's commitment to diversity and inclusion.
Do you work at Karyopharm?
Does Karyopharm actively promote diversity and inclusion?
Karyopharm financial performance
10.0
Performance score
We calculated the performance score of companies by measuring multiple factors, including revenue, longevity, and stock market performance.
Karyopharm currently has 157.1M in revenue. Karyopharm's most recent quarter produced 36.0m (q3'2023).
Karyopharm annual revenue
$210M
$168M
$126M
$84M
$42M
$0
2019
2020
2021
2022
2023
2024
Highest paying Karyopharm competitors
Compare Karyopharm salaries to competitors, including Vertex Pharmaceuticals, Akebia Therapeutics, and Hoffmann-LA Roche Inc. Employees at Vertex Pharmaceuticals earn the highest average yearly salary of $95,952. The salaries at Akebia Therapeutics average $94,635 per year, and the salaries at Hoffmann-LA Roche Inc come in at $93,461 per year.
Rank
Company
Average salary
Jobs
1
$95,952
0
2
$94,635
0
3
$93,461
0
4
$91,725
0
5
$77,053
0
6
$75,012
0
7
$71,494
0
8
$70,481
0
9
$69,296
0
10
$67,230
0
Show more
Are you an executive, HR leader, or brand manager at Karyopharm?
Claiming and updating your company profile on Zippia is free and easy.
Zippia gives an in-depth look into the details of Karyopharm, including salaries, political affiliations, employee data, and more, in order to inform job seekers about Karyopharm. The employee data is based on information from people who have self-reported their past or current employments at Karyopharm. The data on this page is also based on data sources collected from public and open data sources on the Internet and other locations, as well as proprietary data we licensed from other companies. Sources of data may include, but are not limited to, the BLS, company filings, estimates based on those filings, H1B filings, and other public and private datasets. While we have made attempts to ensure that the information displayed are correct, Zippia is not responsible for any errors or omissions or for the results obtained from the use of this information. None of the information on this page has been provided or approved by Karyopharm. The data presented on this page does not represent the view of Karyopharm and its employees or that of Zippia.
Karyopharm may also be known as or be related to KARYOPHARM THERAPEUTICS INC., Karyopharm, Karyopharm Therapeutics, Karyopharm Therapeutics Inc, Karyopharm Therapeutics Inc. and Karyopharm Therapeutics, Inc.